Saifullah Afridi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Saifullah Afridi has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Umar Nishan
Department of Chemistry, Kohat University of Science and Technology, Kohat 26000, KP, Pakistan
5 shared publications - Jamshed Iqbal
Centre for Advanced Drug Research, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, Pakistan
4 shared publications Muhammad Asad
Department of Chemistry, Kohat University of Science and Technology, Kohat 26000, Khyber Pakhtunkhwa, Pakistan
3 shared publications- Muhammad Raza Shah
H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi
3 shared publications Nawshad Muhammad
Department of Dental Materials, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar 25000, Khyber Pukhtunkhwa, Pakistan
3 shared publications- Zhiyuan Wu
Pediatric Intensive Care Unit, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong province, China
3 shared publications
Latest Publications
- 30 October 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (21) , e72348
Design and Evaluation of Compritol–Oleic Acid Nanostructured Lipid Carriers: A New Approach to Type 2 Diabetes Therapy
Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder caused by reduced insulin production and sensitivity. Despite advancements in antidiabetic medications, many patients struggle with poor glycemic control. Combining drugs like sitagliptin (STG) and glipizide (GPZ) can improve treatment efficacy, but their low solubility and rapid excretion limit their effectiveness. To address these challenges, this study developed novel compritol and oleic acid‐based nanostructured lipid carriers (NLCs) for the co‐delivery of STG and GPZ. The NLCs were prepared using a modified microemulsion technique and optimized using the Box–Behnken model, focusing on particle size, zeta potential, and entrapment efficiency. The optimized NLCs exhibited a particle size of 275.5 nm, zeta potential of −23.4 mV, PDI of 0.134, and high entrapment efficiencies of 88% for STG and 85% for GPZ. Characterization was performed using FTIR, XRD, DSC, and TEM techniques. In vitro release studies at pH 1.2, 6.8, and 7.4 demonstrated prolonged drug release from the NLCs compared to pure drug solutions. In vivo studies in a nicotinamide‐streptozotocin‐induced diabetic rat model revealed that STG‐GPZ co‐loaded NLCs (10/2.5 mg/kg/b.w.) significantly improved pancreatic and liver function histology and exhibited synergistic antihyperglycemic effects. Statistical analysis confirmed the significance of these findings, highlighting the potential of STG‐GPZ co‐loaded NLCs as an effective oral drug delivery system for T2DM treatment and management. This innovative approach offers a promising solution to enhance therapeutic outcomes for diabetic patients.
- 30 October 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (21) , e72348
Design and Evaluation of Compritol–Oleic Acid Nanostructured Lipid Carriers: A New Approach to Type 2 Diabetes Therapy
Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder caused by reduced insulin production and sensitivity. Despite advancements in antidiabetic medications, many patients struggle with poor glycemic control. Combining drugs like sitagliptin (STG) and glipizide (GPZ) can improve treatment efficacy, but their low solubility and rapid excretion limit their effectiveness. To address these challenges, this study developed novel compritol and oleic acid‐based nanostructured lipid carriers (NLCs) for the co‐delivery of STG and GPZ. The NLCs were prepared using a modified microemulsion technique and optimized using the Box–Behnken model, focusing on particle size, zeta potential, and entrapment efficiency. The optimized NLCs exhibited a particle size of 275.5 nm, zeta potential of −23.4 mV, PDI of 0.134, and high entrapment efficiencies of 88% for STG and 85% for GPZ. Characterization was performed using FTIR, XRD, DSC, and TEM techniques. In vitro release studies at pH 1.2, 6.8, and 7.4 demonstrated prolonged drug release from the NLCs compared to pure drug solutions. In vivo studies in a nicotinamide‐streptozotocin‐induced diabetic rat model revealed that STG‐GPZ co‐loaded NLCs (10/2.5 mg/kg/b.w.) significantly improved pancreatic and liver function histology and exhibited synergistic antihyperglycemic effects. Statistical analysis confirmed the significance of these findings, highlighting the potential of STG‐GPZ co‐loaded NLCs as an effective oral drug delivery system for T2DM treatment and management. This innovative approach offers a promising solution to enhance therapeutic outcomes for diabetic patients.
- 7 October 2024
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 7 (11) , 3585-3591
Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients
Pancreatic cancer is one of the most lethal and fast-growing cancers with a poor prognosis. Herein, we report the expression of programmed death ligand 1 (PD-L1) as a new prognostic biomarker in pancreatic cancer progression analysis at the clinical level. Immunohistochemistry was performed on 86 clinically proven cases of pancreatic cancer tissue microarrays (TMAs) using anti-PD-L1 antibodies. Histoscore was done, and a variety of cutoffs were identified for analyses of the results. The chi-square test and Kaplan-Meier method were used to find the association between pancreatic cancer and various clinicopathological variables and the overall survival of the patients. PD-L1 expression was associated with histological grade and recurrence of the disease for epithelial and stromal staining at 10 histoscores. In addition, PD-L1 expression was strongly associated with lymph node involvement at the stromal 20 histoscore. The tumor stage of pancreatic cancer had an association with PD-L1 expression with epithelial and stromal 20 histoscores for all comparisons. At a stromal 20 histoscore, overall survival in high-low expression of PD-L1 was 7-19 months, and at a nuclear/cytoplasmic 10 histoscore, it was 9-28 months (p = 0.0001), respectively. Overall, PD-L1 overexpression in subcellular compartments was associated with disease aggression phenotypes and poor patient survival. Overexpression of PD-L1 was directly linked to pancreatic cancer progression and a poor survival rate. Therefore, PD-L1 may be used as a prognostic biomarker in the diagnosis, treatment, and management of pancreatic cancer patients.
- 7 October 2024
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 7 (11) , 3585-3591
Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients
Pancreatic cancer is one of the most lethal and fast-growing cancers with a poor prognosis. Herein, we report the expression of programmed death ligand 1 (PD-L1) as a new prognostic biomarker in pancreatic cancer progression analysis at the clinical level. Immunohistochemistry was performed on 86 clinically proven cases of pancreatic cancer tissue microarrays (TMAs) using anti-PD-L1 antibodies. Histoscore was done, and a variety of cutoffs were identified for analyses of the results. The chi-square test and Kaplan-Meier method were used to find the association between pancreatic cancer and various clinicopathological variables and the overall survival of the patients. PD-L1 expression was associated with histological grade and recurrence of the disease for epithelial and stromal staining at 10 histoscores. In addition, PD-L1 expression was strongly associated with lymph node involvement at the stromal 20 histoscore. The tumor stage of pancreatic cancer had an association with PD-L1 expression with epithelial and stromal 20 histoscores for all comparisons. At a stromal 20 histoscore, overall survival in high-low expression of PD-L1 was 7-19 months, and at a nuclear/cytoplasmic 10 histoscore, it was 9-28 months (p = 0.0001), respectively. Overall, PD-L1 overexpression in subcellular compartments was associated with disease aggression phenotypes and poor patient survival. Overexpression of PD-L1 was directly linked to pancreatic cancer progression and a poor survival rate. Therefore, PD-L1 may be used as a prognostic biomarker in the diagnosis, treatment, and management of pancreatic cancer patients.
- Open Access
- 16 November 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (47) , 44931-44941
Paracetamol-Mediated Synthesis of Silver Nanoparticles and Their Functionalization with Ionic Liquid for the Colorimetric Biosensing of Ascorbic Acid
Ascorbic acid is a vital biomolecule for human beings. When the body's level of ascorbic acid is abnormal, it can lead to a number of illnesses. Its appropriate concentration is necessary for the oxidation of prostaglandins and cyclic adenosine monophosphate, the production of dopamine, norepinephrine, epinephrine, and carnitine, and the expansion and durability of the collagen triple helix in humans. In the present work, silver nanoparticle synthesis was performed through a paracetamol-mediated approach. Different characterization techniques, such as X-ray diffractometry (XRD), energy dispersive X-ray (EDX), Fourier transform infrared (FTIR), and scanning electron microscopy (SEM), were used to confirm the prepared nanoparticles. Subsequently, the prepared Ag NPs functionalized with an ionic liquid were used as a sensing platform for ascorbic acid in blood serum samples. To achieve the best possible results, the proposed biosensor was optimized with different parameters such as TMB concentration, time, amount of capped nanoparticles (NPs), and pH. The proposed biosensor offers a sensitive and straightforward method for ascorbic acid with a linear range from 2 × 10-9 to 3.22 × 10-7 M, an LOD of 1.3 × 10-8 M, an LOQ of 4.3 × 10-8 M, and an R2 of 0.9996, Moreover, applications of the proposed biosensor were successfully used for the detection of ascorbic acid in samples of human plasma, suggesting that Ag NPs with high peroxidase-like activity, high stability, and facile synthesis exhibited promising applications in biomedical fields.
- 16 November 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (47) , 44931-44941
Open AccessParacetamol-Mediated Synthesis of Silver Nanoparticles and Their Functionalization with Ionic Liquid for the Colorimetric Biosensing of Ascorbic Acid
Ascorbic acid is a vital biomolecule for human beings. When the body's level of ascorbic acid is abnormal, it can lead to a number of illnesses. Its appropriate concentration is necessary for the oxidation of prostaglandins and cyclic adenosine monophosphate, the production of dopamine, norepinephrine, epinephrine, and carnitine, and the expansion and durability of the collagen triple helix in humans. In the present work, silver nanoparticle synthesis was performed through a paracetamol-mediated approach. Different characterization techniques, such as X-ray diffractometry (XRD), energy dispersive X-ray (EDX), Fourier transform infrared (FTIR), and scanning electron microscopy (SEM), were used to confirm the prepared nanoparticles. Subsequently, the prepared Ag NPs functionalized with an ionic liquid were used as a sensing platform for ascorbic acid in blood serum samples. To achieve the best possible results, the proposed biosensor was optimized with different parameters such as TMB concentration, time, amount of capped nanoparticles (NPs), and pH. The proposed biosensor offers a sensitive and straightforward method for ascorbic acid with a linear range from 2 × 10-9 to 3.22 × 10-7 M, an LOD of 1.3 × 10-8 M, an LOQ of 4.3 × 10-8 M, and an R2 of 0.9996, Moreover, applications of the proposed biosensor were successfully used for the detection of ascorbic acid in samples of human plasma, suggesting that Ag NPs with high peroxidase-like activity, high stability, and facile synthesis exhibited promising applications in biomedical fields.
- 28 March 2023
- Published by Springer Nature in Arabian Journal for Science and Engineering
- Vol. 48 (6) , 7703-7712
Investigation of Silver-Doped Iron Oxide Nanostructures Functionalized with Ionic Liquid for Colorimetric Sensing of Hydrogen Peroxide
- 28 March 2023
- Published by Springer Nature in Arabian Journal for Science and Engineering
- Vol. 48 (6) , 7703-7712
Investigation of Silver-Doped Iron Oxide Nanostructures Functionalized with Ionic Liquid for Colorimetric Sensing of Hydrogen Peroxide
- Open Access
- 20 July 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (30) , 26983-26991
Development of a Nonenzymatic Colorimetric Sensor for the Detection of Uric Acid Based on Ionic Liquid-Mediated Nickel Nanostructures
Uric acid (UA) is a metabolic byproduct of purine nucleotides and is excreted as a urine component. Abnormalities in UA metabolism cause localized inflammation due to crystal deposition and can lead to various diseases. In the current study, we successfully fabricated a biosensor based on 1-H-3-methylimidazolium acetate (ionic liquid, IL)-capped nickel nanoparticles (NiNPs) for the detection of uric acid in test samples. The structures of IL-capped NiNPs and their precursors were characterized by Fourier transform infrared spectroscopy, scanning electron microscopy, and X-ray diffraction. The IL-capped NiNPs possessed intrinsic peroxidase-like properties and displayed selective UA quenching after interacting with 3,3',5,5'-tetramethylbenzidine (TMB) solution. Different parameters such as pH, time, IL, TMB, and UA concentration were optimized to obtain the best results for the proposed sensor. The UA biosensor shows good responses in the linear range from 1 × 10-8 to 2.40 × 10-6 M, with a lower limit of detection of 1.30 × 10-7 M, a limit of quantification of 4.3 × 10-7 M, and an R 2 value of 0.9994. For the colorimetric detection of UA, the proposed sensor gave a short time response of 4 min at room temperature and pH 7.5. The proposed sensing probe detects UA in real serum samples and could be used as a selective sensor for UA in the real sample detection.
- 20 July 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (30) , 26983-26991
Open AccessDevelopment of a Nonenzymatic Colorimetric Sensor for the Detection of Uric Acid Based on Ionic Liquid-Mediated Nickel Nanostructures
Uric acid (UA) is a metabolic byproduct of purine nucleotides and is excreted as a urine component. Abnormalities in UA metabolism cause localized inflammation due to crystal deposition and can lead to various diseases. In the current study, we successfully fabricated a biosensor based on 1-H-3-methylimidazolium acetate (ionic liquid, IL)-capped nickel nanoparticles (NiNPs) for the detection of uric acid in test samples. The structures of IL-capped NiNPs and their precursors were characterized by Fourier transform infrared spectroscopy, scanning electron microscopy, and X-ray diffraction. The IL-capped NiNPs possessed intrinsic peroxidase-like properties and displayed selective UA quenching after interacting with 3,3',5,5'-tetramethylbenzidine (TMB) solution. Different parameters such as pH, time, IL, TMB, and UA concentration were optimized to obtain the best results for the proposed sensor. The UA biosensor shows good responses in the linear range from 1 × 10-8 to 2.40 × 10-6 M, with a lower limit of detection of 1.30 × 10-7 M, a limit of quantification of 4.3 × 10-7 M, and an R 2 value of 0.9994. For the colorimetric detection of UA, the proposed sensor gave a short time response of 4 min at room temperature and pH 7.5. The proposed sensing probe detects UA in real serum samples and could be used as a selective sensor for UA in the real sample detection.
- 1 June 2021
- Published by Elsevier in Bioorganic Chemistry
- Vol. 111, 104908
Small organic molecules accelerate the expansion of regulatory T cells
- 1 June 2021
- Published by Elsevier in Bioorganic Chemistry
- Vol. 111, 104908
Small organic molecules accelerate the expansion of regulatory T cells
- 10 November 2019
- Published by Wiley in International Journal of Cancer
- Vol. 146 (7) , 1993-2006
Highly immunosuppressive HLADRhi regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma
Regulatory T cells (Tregs) are crucial for the maintenance of peripheral tolerance, but they also limit beneficial responses through cancer‐induced immunoediting. The roles of Treg subsets in cervical squamous cell carcinoma (CSCC) are currently unknown. Here, we aimed to perform an extensive study with an increased resolution of the Treg compartment in the peripheral blood and tumor tissues of CSCC patients. We first identified that an HLADRhi Treg population in the peripheral blood was significantly increased in CSCC patients compared to precancer patients and healthy donors. We found that HLADRhi Tregs express high levels of a panel of inhibition and activation markers and the TCR‐responsive transcription factors BATF and IRF4. However, this Treg subset showed reduced calcium influx after TCR crosslinking. In addition, HLADRhi Tregs are highly proliferative and vulnerable to apoptosis. Further studies demonstrated that the HLADRhi Tregs display high levels of suppressive activity. Quantitative multiplexed immunohistochemistry revealed that an increase in the number of tumor‐infiltrating HLADRhi Tregs is associated with unfavorable classical risk parameters of advanced disease stage and stromal invasion. Context‐based quantification revealed that a high frequency of stromal HLADRhi Tregs in patients is significantly associated with worse progression‐free survival. In the current study, we characterized a population of highly activated and immunosuppressive HLADRhi Tregs in CSCC patients. An increased HLADRhi Treg frequency may be a potential biomarker to stratify CSCC patients and evaluate therapeutic efficacies in personalized immuno‐oncology studies.
- 10 November 2019
- Published by Wiley in International Journal of Cancer
- Vol. 146 (7) , 1993-2006
Highly immunosuppressive HLADRhi regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma
Regulatory T cells (Tregs) are crucial for the maintenance of peripheral tolerance, but they also limit beneficial responses through cancer‐induced immunoediting. The roles of Treg subsets in cervical squamous cell carcinoma (CSCC) are currently unknown. Here, we aimed to perform an extensive study with an increased resolution of the Treg compartment in the peripheral blood and tumor tissues of CSCC patients. We first identified that an HLADRhi Treg population in the peripheral blood was significantly increased in CSCC patients compared to precancer patients and healthy donors. We found that HLADRhi Tregs express high levels of a panel of inhibition and activation markers and the TCR‐responsive transcription factors BATF and IRF4. However, this Treg subset showed reduced calcium influx after TCR crosslinking. In addition, HLADRhi Tregs are highly proliferative and vulnerable to apoptosis. Further studies demonstrated that the HLADRhi Tregs display high levels of suppressive activity. Quantitative multiplexed immunohistochemistry revealed that an increase in the number of tumor‐infiltrating HLADRhi Tregs is associated with unfavorable classical risk parameters of advanced disease stage and stromal invasion. Context‐based quantification revealed that a high frequency of stromal HLADRhi Tregs in patients is significantly associated with worse progression‐free survival. In the current study, we characterized a population of highly activated and immunosuppressive HLADRhi Tregs in CSCC patients. An increased HLADRhi Treg frequency may be a potential biomarker to stratify CSCC patients and evaluate therapeutic efficacies in personalized immuno‐oncology studies.
- 1 September 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 27 (17) , 3889-3901
Sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as potent carbonic anhydrase II/IX/XII inhibitors
- 1 September 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 27 (17) , 3889-3901
Sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as potent carbonic anhydrase II/IX/XII inhibitors
- Open Access
- 1 February 2019
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 26 (2) , 281-285
A comparative toxic effect of Cedrus deodara oil on larval protein contents and its behavioral effect on larvae of mealworm beetle (Tenebrio molitor) (Coleoptera: Tenebrionidae)
- 1 February 2019
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 26 (2) , 281-285
Open AccessA comparative toxic effect of Cedrus deodara oil on larval protein contents and its behavioral effect on larvae of mealworm beetle (Tenebrio molitor) (Coleoptera: Tenebrionidae)